A novel vacuum ultra violet lamp for metastable rare gas experiments

We report on a new design of a vacuum ultra violet (VUV) lamp for direct optical excitation of high laying atomic states e.g. for excitation of metastable rare gas atoms. The lamp can be directly mounted to ultra high vacuum vessels (p <= 10^(-10) mbar). It is driven by a 2.45 GHz microwave source. For optimum operation it requires powers of approximately 20 W. The VUV light is transmitted through a magnesium fluoride window, which is known to have a decreasing transmittance for VUV photons with time. In our special setup, after a run-time of the VUV lamp of 550 h the detected signal continuously decreased to 25 % of its initial value. This corresponds to a lifetime increase of two orders of magnitude compared to previous setups or commercial lamps

A novel vacuum ultra violet lamp for metastable rare gas experiments

We report on a new design of a vacuum ultra violet (VUV) lamp for direct optical excitation of high laying atomic states e.g. for excitation of metastable rare gas atoms. The lamp can be directly mounted to ultra high vacuum vessels (p <= 10^(-10) mbar). It is driven by a 2.45 GHz microwave source. For optimum operation it requires powers of approximately 20 W. The VUV light is transmitted through a magnesium fluoride window, which is known to have a decreasing transmittance for VUV photons with time. In our special setup, after a run-time of the VUV lamp of 550 h the detected signal continuously decreased to 25 % of its initial value. This corresponds to a lifetime increase of two orders of magnitude compared to previous setups or commercial lamps

Fluorodeoxyglucose Positron Emission Tomography in Primary Thyroid Lymphoma with Coexisting Lymphocytic Thyroiditis

Background: Primary thyroid lymphoma is an uncommon neoplasm frequently associated with lymphocytic thyroiditis (LT). Once the pathologic diagnosis of primary thyroid lymphoma is established, imaging plays an important role in tumor staging and evaluating treatment response. The present case discusses the role of fluorodeoxyglucose positron emission tomography (18F-FDG PET)/computed tomography (CT) in this clinical setting along with the potential diagnostic challenges. Patient Findings: A 44-year-old man with a history of LT and hypothyroidism presented with an enlarging goiter. Initial imaging evaluation showed markedly enlarged gland with bilateral cervical and mediastinal adenopathy. Histopathologic evaluation confirmed the diagnosis of primary thyroid lymphoma on a background of LT. An 18F-FDG PET/CT revealed increased uptake in the gland and lymph nodes. Follow-up 18F-FDG PET/CT after chemotherapy showed interval decrease in FDG uptake in the thyroid gland associated with interval decrease in the size and metabolic activity of the cervical and superior mediastinal lymph nodes. Conclusions: The frequent association of LT with primary thyroid lymphoma and the overlap of their clinical and pathologic findings pose a significant diagnostic challenge. While other imaging techniques are helpful in evaluating anatomic local and regional extent of primary thyroid lymphoma, 18F-FDG PET/CT can be of an added value in evaluating its metabolic activity and detecting regional and distant disease as well as in assessing response to treatment.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90467/1/thy-2E2011-2E0064.pd

Constraints on chiral operators in N=2 SCFTs

Open Access, © The Authors. Article funded by SCOAP3. This article is distributed under the terms of the Creative Commons Attribution License ( CC-BY 4.0 ), which permits any use, distribution and reproduction in any medium, provided the original author(s) and source are credited

Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.

Background Whether hydrocortisone reduces mortality among patients with septic shock is unclear. Methods We randomly assigned patients with septic shock who were undergoing mechanical ventilation to receive hydrocortisone (at a dose of 200 mg per day) or placebo for 7 days or until death or discharge from the intensive care unit (ICU), whichever came first. The primary outcome was death from any cause at 90 days. Results From March 2013 through April 2017, a total of 3800 patients underwent randomization. Status with respect to the primary outcome was ascertained in 3658 patients (1832 of whom had been assigned to the hydrocortisone group and 1826 to the placebo group). At 90 days, 511 patients (27.9%) in the hydrocortisone group and 526 (28.8%) in the placebo group had died (odds ratio, 0.95; 95% confidence interval [CI], 0.82 to 1.10; P=0.50). The effect of the trial regimen was similar in six prespecified subgroups. Patients who had been assigned to receive hydrocortisone had faster resolution of shock than those assigned to the placebo group (median duration, 3 days [interquartile range, 2 to 5] vs. 4 days [interquartile range, 2 to 9]; hazard ratio, 1.32; 95% CI, 1.23 to 1.41; P<0.001). Patients in the hydrocortisone group had a shorter duration of the initial episode of mechanical ventilation than those in the placebo group (median, 6 days [interquartile range, 3 to 18] vs. 7 days [interquartile range, 3 to 24]; hazard ratio, 1.13; 95% CI, 1.05 to 1.22; P<0.001), but taking into account episodes of recurrence of ventilation, there were no significant differences in the number of days alive and free from mechanical ventilation. Fewer patients in the hydrocortisone group than in the placebo group received a blood transfusion (37.0% vs. 41.7%; odds ratio, 0.82; 95% CI, 0.72 to 0.94; P=0.004). There were no significant between-group differences with respect to mortality at 28 days, the rate of recurrence of shock, the number of days alive and out of the ICU, the number of days alive and out of the hospital, the recurrence of mechanical ventilation, the rate of renal-replacement therapy, and the incidence of new-onset bacteremia or fungemia. Conclusions Among patients with septic shock undergoing mechanical ventilation, a continuous infusion of hydrocortisone did not result in lower 90-day mortality than placebo. (Funded by the National Health and Medical Research Council of Australia and others; ADRENAL ClinicalTrials.gov number, NCT01448109 .)

Venous thromboembolic events in critically ill traumatic brain injury patients

To estimate the prevalence, risk factors, prophylactic treatment and impact on mortality for venous thromboembolism (VTE) in patients with moderate to severe traumatic brain injury (TBI) treated in the intensive care unit. A post hoc analysis of the erythropoietin in traumatic brain injury (EPO-TBI) trial that included twice-weekly lower limb ultrasound screening. Venous thrombotic events were defined as ultrasound-proven proximal deep venous thrombosis (DVT) or clinically detected pulmonary embolism (PE). Results are reported as events, percentages or medians and interquartile range (IQR). Cox regression analysis was used to calculate adjusted hazard ratios (HR) with 95% confidence intervals (CI) for time to VTE and death. Of 603 patients, 119 (19.7%) developed VTE, mostly comprising DVT (102 patients, 16.9%) with a smaller number of PE events (24 patients, 4.0%). Median time to DVT diagnosis was 6 days (IQR 2-11) and to PE diagnosis 6.5 days (IQR 2-16.5). Mechanical prophylaxis (MP) was used in 91% of patients on day 1, 97% of patients on day 3 and 98% of patients on day 7. Pharmacological prophylaxis was given in 5% of patients on day 1, 30% of patients on day 3 and 57% of patients on day 7. Factors associated with time to VTE were age (HR per year 1.02, 95% CI 1.01-1.03), patient weight (HR per kg 1.01, 95% CI 1-1.02) and TBI severity according to the International Mission for Prognosis and Analysis of Clinical Trials risk of poor outcome (HR per 10% increase 1.12, 95% CI 1.01-1.25). The development of VTE was not associated with mortality (HR 0.92, 95% CI 0.51-1.65). Despite mechanical and pharmacological prophylaxis, VTE occurs in one out of every five patients with TBI treated in the ICU. Higher age, greater weight and greater severity of TBI increase the risk. The development of VTE was not associated with excess mortality.Peer reviewe

Degré d’impact des aménagements hydrauliques sur le ruissellement et le transport solide dans une région semi aride : cas des micro-bassins dans le haut Isser, Algérie

L’érosion est un ensemble de processus variables dans le temps et dans l'espace. La variation se fait en fonction des conditions écologiques et des mauvaises conditions de gestion de la terre par l'homme. C’est pourquoi la lutte antiérosive intéresse divers acteurs dont les intérêts ne sont pas forcément compatibles. Ses effets sont conséquents sur les ressources en eau par la réduction de la capacité de stockage des barrages et la mauvaise qualité de l’eau, d’une part, et sur le sol par la perte de sa fertilité, d’autre part. En Algérie septentrionale, ce phénomène est crucial. De nombreux chercheurs se sont penchés pour traiter ce problème ; que ce soit dans l’aspect de quantification que dans celui de la lutte anti-érosive. Nous avons tenté d’approcher le phénomène dans ces deux aspects, en prenant comme zone d’étude les micro-bassins 'expérimentaux de Beni Slimane, dans le bassin versant de lOued Isser. L’intensité de l’érosion hydrique sur ce bassin versant s’explique par la prédominance des terrains marneux, des ruissellements concentrés et un couvert végétal quasi inexistant. L’impact des aménagements  hydrauliques sur le ruissellement a été démontré sur les micros bassins expérimentaux. C’est dans cette optique que s’inscrit l’objectif de ce travail, vu l’importance que revêt la région par rapport à son alimentation en eau potable de la capitale, d’une part, et à une agriculture florissante, d’autre part.Mots-clés : capacité de stockage, érosion, ruissellement, impact, micros bassins expérimentau